Estepan Ian Michael 4

What Happened
Estepan Ian Michael, Chief Operating Officer of Sarepta Therapeutics (SRPT), had 1,097 shares withheld by the company on March 11, 2026 to satisfy tax withholding obligations related to vesting of restricted stock units. The shares were reported at $17.03 each for a total value of $18,682. This was a tax-withholding/net-settlement event (transaction code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-03-11; Filing date: 2026-03-13 (appears timely).
• Price per share: $17.03; Shares withheld/disposed: 1,097; Total value: $18,682.
• Shares owned after transaction: Not disclosed in this Form 4.
• Footnote: Shares were withheld to satisfy tax withholding on RSUs granted March 10, 2025 (F1).
• Transaction type: F = tax withholding/net settlement (routine, not a market trade).

Context
Withholding shares to cover taxes on vested RSUs is common executive compensation administration and does not necessarily signal insider confidence or concern. This was an administrative disposition rather than a voluntary sale; treat it as routine reporting of tax withholding rather than a deliberate investment decision.